Impaired platelet activation and cAMP homeostasis in MRP4-deficient mice

Blood

Volumn 126, Issue 15, 2015, Pages 1823-1830

  Decouture, Benoit ^a,b   Dreano, Elise ^a,b   Belleville Rolland, Tiphaine ^a,b,c   Kuci, Orjeta ^a,b   Dizier, Blandine ^a,b   Bazaa, Amine ^a   Coqueran, Bérard ^b,d   Lompre, Anne Marie ^e,f   Denis, Cécile V ^a   Hulot, Jean Sébastien ^e,f   Bachelot Loza, Christilla ^a,b   Gaussem, Pascale ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d Faculté de Pharmacie   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA2B BETA3 INTEGRIN; COLLAGEN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; INTEGRIN; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 4; UNCLASSIFIED DRUG; VASODILATOR STIMULATED PHOSPHOPROTEIN; ABCC4 PROTEIN, MOUSE; MULTIDRUG RESISTANCE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY OCCLUSION; ARTICLE; BLEEDING; BLEEDING TIME; BLOOD CLOTTING; CONTROLLED STUDY; CYTOSOL; HOMEOSTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE RELEASE REACTION; THROMBOCYTE STRUCTURE; THROMBOCYTE TRANSFUSION; ANIMAL; BLOOD CLOTTING PARAMETERS; CELL CULTURE; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; THROMBOSIS; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD PLATELETS; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HOMEOSTASIS; MICE; MICE, KNOCKOUT; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PHOSPHORYLATION; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; SIGNAL TRANSDUCTION; THROMBOSIS;

EID: 84943620384     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-02-631044     Document Type: Article

References (34)

1. Radomski MW, Palmer RM, Moncada S. Comparative pharmacology of endotheliumderived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol. 1987; 92(1):181-187.
2. Smolenski A. Novel roles of cAMP/cGMPdependent signaling in platelets. J Thromb Haemost. 2012;10(2):167-176.
3. Haslam RJ, McClenaghan MD. Effects of collagen and of aspirin on the concentration of guanosine 39:59-cyclic monophosphate in human blood platelets: measurement by a prelabelling technique. Biochem J. 1974; 138(2):317-320.
4. Riba R, Oberprieler NG, Roberts W, Naseem KM. Von Willebrand factor activates endothelial nitric oxide synthase in blood platelets by a glycoprotein Ib-dependent mechanism. J Thromb Haemost. 2006;4(12):2636-2644.
5. Gambaryan S, Kobsar A, Hartmann S, et al. NO-synthase-/NO-independent regulation of human and murine platelet soluble guanylyl cyclase activity. J Thromb Haemost. 2008;6(8): 1376-1384.
6. Beck F, Geiger J, Gambaryan S, et al. Time-resolved characterization of cAMP/PKAdependent signaling reveals that platelet inhibition is a concerted process involving multiple signaling pathways. Blood. 2014; 123(5):e1-e10.
7. Smolenski A, Bachmann C, Reinhard K, et al. Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody. J Biol Chem. 1998;273(32): 20029-20035.
8. Haslam RJ, Dickinson NT, Jang EK. Cyclic nucleotides and phosphodiesterases in platelets. Thromb Haemost. 1999;82(2): 412-423.
9. Hechler B, Gachet C. P2 receptors and platelet function. Purinergic Signal. 2011;7(3):293-303.
10. Gurbel PA, Tantry US. Combination antithrombotic therapies. Circulation. 2010; 121(4):569-583.
11. Tantry US, Bonello L, Aradi D, et al; Working Group on On-Treatment Platelet Reactivity. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J Am Coll Cardiol. 2013;62(24): 2261-2273.
12. Chen ZS, Lee K, Kruh GD. Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine. J Biol Chem. 2001;276(36):33747-33754.
13. Russel FG, Koenderink JB, Masereeuw R. Multidrug resistance protein 4 (MRP4/ABCC4): A versatile efflux transporter for drugs and signalling molecules. Trends Pharmacol Sci. 2008;29(4):200-207.
14. Cheepala S, Hulot JS, Morgan JA, et al. Cyclic nucleotide compartmentalization: contributions of phosphodiesterases and ATP-binding cassette transporters. Annu Rev Pharmacol Toxicol. 2013; 53:231-253.
15. Sassi Y, Lipskaia L, Vandecasteele G, et al. Multidrug resistance-associated protein 4 regulates cAMP-dependent signaling pathways and controls human and rat SMC proliferation. J Clin Invest. 2008;118(8): 2747-2757.
16. Sassi Y, Abi-Gerges A, Fauconnier J, et al. Regulation of cAMP homeostasis by the efflux protein MRP4 in cardiac myocytes. FASEB J. 2012;26(3):1009-1017.
17. Hara Y, Sassi Y, Guibert C, et al. Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice. J Clin Invest. 2011;121(7): 2888-2897.
18. Jedlitschky G, Tirschmann K, Lubenow LE, et al. The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage. Blood. 2004;104(12): 3603-3610.
19. Jedlitschky G, Cattaneo M, Lubenow LE, et al. Role of MRP4 (ABCC4) in platelet adenine nucleotide-storage: evidence from patients with delta-storage pool deficiencies. Am J Pathol. 2010;176(3):1097-1103.
20. Borgognone A, Pulcinelli FM. Reduction of cAMP and cGMP inhibitory effects in human platelets by MRP4-mediated transport. Thromb Haemost. 2012;108(5):955-962.
21. Leggas M, Adachi M, Scheffer GL, et al. Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Mol Cell Biol. 2004; 24(17):7612-7621.
22. Ritter CA, Jedlitschky G, Meyerzu-Schwabedissen H, Grube M, Köck K, Kroemer HK. Cellular export of drugs and signaling molecules by the ATP-binding cassette transporters MRP4 (ABCC4) and MRP5 (ABCC5). Drug Metab Rev. 2005;37(1): 253-278.
23. Köck K, Grube M, Jedlitschky G, et al. Expression of adenosine triphosphate-binding cassette (ABC) drug transporters in peripheral blood cells: relevance for physiology and pharmacotherapy. Clin Pharmacokinet. 2007; 46(6):449-470.
24. Jedlitschky G, Burchell B, Keppler D. The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides. J Biol Chem. 2000;275(39): 30069-30074.
25. Lien LM, Chen ZC, Chung CL, et al. Multidrug resistance protein 4 (MRP4/ABCC4) regulates thrombus formation in vitro and in vivo. Eur J Pharmacol. 2014;737:159-167.
26. Hiasa M, Togawa N, Miyaji T, Omote H, Yamamoto A, Moriyama Y. Essential role of vesicular nucleotide transporter in vesicular storage and release of nucleotides in platelets. Physiol Rep. 2014;2(6):e12034.
27. Sawada K, Echigo N, Juge N, et al. Identification of a vesicular nucleotide transporter. Proc Natl Acad Sci USA. 2008;105(15):5683-5686.
28. Andric SA, Kostic TS, Stojilkovic SS. Contribution of multidrug resistance protein MRP5 in control of cyclic guanosine 59-monophosphate intracellular signaling in anterior pituitary cells. Endocrinology. 2006;147(7):3435-3445.
29. Oevermann L, Scheitz J, Starke K, et al. Hematopoietic stem cell differentiation affects expression and function of MRP4 (ABCC4), a transport protein for signaling molecules and drugs. Int J Cancer. 2009;124(10):2303-2311.
30. Agarwal SR, Yang PC, Rice M, et al. Role of membrane microdomains in compartmentation of cAMP signaling. PLoS One. 2014;9(4): e95835.
31. Begonja AJ, Gambaryan S, Schulze H, et al. Differential roles of cAMP and cGMP in megakaryocyte maturation and platelet biogenesis. Exp Hematol. 2013;41(1): 91-101.e4.
32. Broderdorf S, Zang S, Schaletzki Y, Grube M, Kroemer HK, Jedlitschky G. cAMP regulates expression of the cyclic nucleotide transporter MRP4 (ABCC4) through the EPAC pathway. Pharmacogenet Genomics. 2014;24(10): 522-526.
33. Mattiello T, Guerriero R, Lotti LV, et al. Aspirin extrusion from human platelets through multidrug resistance protein-4-mediated transport: evidence of a reduced drug action in patients after coronary artery bypass grafting. J Am Coll Cardiol. 2011; 58(7):752-761.
34. Massimi I, Guerriero R, Lotti LV, et al. Aspirin influences megakaryocytic gene expression leading to up-regulation of multidrug resistance protein-4 in human platelets. Br J Clin Pharmacol. 2014;78(6): 1343-1353.